We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
(+7.7%)
Cap. Flow
+$2.23B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$520M |
| 2 |
UnitedHealth
UNH
|
+$332M |
| 3 |
Analog Devices
ADI
|
+$320M |
| 4 |
Fidelity National Information Services
FIS
|
+$265M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$516M |
| 2 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$512M |
| 3 |
Cisco
CSCO
|
+$348M |
| 4 |
Apple
AAPL
|
+$162M |
| 5 |
Devon Energy
DVN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Financials | 8.92% |
| 3 | Healthcare | 7.98% |
| 4 | Industrials | 6.57% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Stem
STEM
$47.7M
| $57K | ﹤0.01% |
8,190
+276
| +3% | +$4.34K |
|
3827
SelectQuote
SLQT
$132M
| $56.4K | ﹤0.01% |
26,000
| – | – |
|
3828
Akebia Therapeutics
AKBA
$341M
| $55.9K | ﹤0.01% |
42,311
-8,928
| -17% | -$11.9K |
|
|
SLI
3829
Standard Lithium
SLI
$493M
| $55.7K | ﹤0.01% |
34,588
-100
| -0.3% | -$129 |
|
|
MIN
3830
Aberdeen Intermediate Income Fund
MIN
$273M
| $55.1K | ﹤0.01% |
20,247
-4,856
| -19% | -$13.2K |
|
3831
FibroBiologics
FBLG
$3.95M
| $54.5K | ﹤0.01% |
882
| – | – |
|
3832
Village Farms International
VFF
$250M
| $54.3K | ﹤0.01% |
58,374
-13,581
| -19% | -$13.9K |
|
|
EDF
3833
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$167M
| $54.2K | ﹤0.01% |
10,343
| – | – |
|
3834
PUT
Adobe
ADBE
$99B
| $53K | ﹤0.01% |
100
| – | – |
|
3835
BRC Inc
BRCC
$118M
| $52.8K | ﹤0.01% |
15,442
-17,384
| -53% | -$79.7K |
|
3836
Oxford Square Capital
OXSQ
$147M
| $52.1K | ﹤0.01% |
18,422
| – | – |
|
3837
Clean Energy Fuels
CLNE
$421M
| $50.7K | ﹤0.01% |
16,315
-2,956
| -15% | -$8.38K |
|
3838
Anixa Biosciences
ANIX
$120M
| $49.6K | ﹤0.01% |
15,752
-2,003
| -11% | -$6.16K |
|
3839
Agilon Health
AGL
$1.65B
| $49.4K | ﹤0.01% |
503
-4
| -0.8% | -$517 |
|
3840
Denison Mines
DNN
$2.49B
| $48.5K | ﹤0.01% |
26,530
+9,350
| +54% | +$16.4K |
|
3841
Red Cat Holdings
RCAT
$1.13B
| $47.7K | ﹤0.01% |
+18,780
| New | +$44.7K |
|
3842
PUT
Nutrien
NTR
$33.3B
| $47.5K | ﹤0.01% |
+1,000
| New | +$48.2K |
|
3843
AlTi Global
ALTI
$402M
| $46.2K | ﹤0.01% |
+12,345
| New | +$53.2K |
|
3844
Opendoor
OPEN
$3.8B
| $44.9K | ﹤0.01% |
23,210
+2,424
| +12% | +$4.92K |
|
3845
IHS Holding
IHS
$2.78B
| $44.9K | ﹤0.01% |
15,000
| – | – |
|
3846
PDS Biotechnology
PDSB
$38.6M
| $44.8K | ﹤0.01% |
11,731
-2,121
| -15% | -$7.08K |
|
3847
Absci
ABSI
$1.21B
| $44.3K | ﹤0.01% |
+11,588
| New | +$46.1K |
|
|
OPTU
3848
Optimum Communications Inc
OPTU
$298M
| $44.1K | ﹤0.01% |
17,921
-3,707,866
| -100% | -$7.16M |
|
3849
PUT
VICI Properties
VICI
$29.8B
| $44K | ﹤0.01% |
1,600
| – | – |
|
|
RJET
3850
Republic Airways Holdings
RJET
$863M
| $43.8K | ﹤0.01% |
2,413
-66
| -3% | -$1.36K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
- Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
- Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
- Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
- Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
- Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
- Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.